Subjects: Computers, computer technology, software
Lonza and NNIT partner to speed up MES projects
Across the life sciences industry, pharma companies are seeking new ways to respond to the high agility required to produce complex products like personalized cancer treatment, cell and gene therapy and Covid-19 vaccines. Central to these efforts is the manufacturing execution system (MES), which allows pharma companies to adopt pharma 4.0 production and manage their data flows to expedite product
Student Assistant in NNIT: Meet Rasmus
At NNIT, we employ a number of students and interns who are excited about the digital transformation and want to play an important role in fulfilling our customers' IT potential in different ways. Rasmus Roug Nyeland is one of them.
NNIT signs largest Veeva deal to date
NNIT recently signed its largest Veeva deal to date with a global top-10 life sciences company.
NNIT and BA Insight partner to accelerate clinical trials
NNIT and BA Insight enters new partnership
NNIT Talents acknowledged by Tech Publishing
Every year, the Danish organization Tech Publishing casts light on the many skilled IT specialists working in Denmark by announcing three IT Talent Top 10s. Among the 2020 nominees were nine NNIT employees, three of them made the cut.
The importance of ensuring drug safety
We asked Jesper Borgstrøm, Advanced Advisory Consultant, NNIT Life Sciences – Regulatory Affairs, to take us through the safety aspects of one of the world’s most regulated product development and manufacturing processes.
NNIT colleagues make their mark on Danish education
Meet Lasse Lanng Pedersen and Martin Vang Jeppesen who on a daily basis make the NNIT wheels spin at our datacenter in Bagsværd, Denmark. After office hours, they spend time sharing their expert knowledge with the future datacenter specialists of Denmark by teaching at Copenhagen School of Marine Engineering and Technology Management.
5G will be the next big thing
NNIT has been testing 5G against 4G and regular cable internet connections across different devices, and the verdict is here: it works, and it can process more data quicker and in a better quality than traditional internet/fiber net.
NNIT partner with Danish-based financial technology disruptor, NES TECH, to challenge the current software environment in the pension industry.
Copenhagen, September 11, 2020 – NNIT, a leading provider of IT services and consultancy is partnering with Danish-based NES TECH, who is behind the software application, Polaris - a challenger to the established software environment in the pension industry.The Danish pension industry has for a long time been relying on a limited selection of legacy software and service suppliers to accommodate th
NNIT signs Solution Provider Program agreement with AWS
Copenhagen, August 27 2020 – NNIT, a leading provider of IT services and consultancy is now deepening the cooperation with Amazon Web Services (AWS) by signing a Solution Provider Program (SPP) agreement. NNIT is now able to manage, service, support and bill customers using AWS, while customers have their own terms with AWS.The demand for AWS cloud services continues to grow globally. This has led
NNIT and DLG extend and expand collaboration
According to the new agreement, NNIT will for the next five years support DLG’s transformation towards a more cloud-based IT-infrastructure and group-wide services.
NNIT and Microsoft collaborate on cloud based standard solutions
Two of the biggest players in the Danish IT-market connect to help Danish companies release their cloud potential.
NNIT announces partnership with Dell Boomi
NNIT, a leading provider of IT services and consultancy strengthens its position in cloud system integration in Denmark by entering into a new partnership with Dell Boomi.
New Cloud Removes Barriers for Life Sciences
New hybrid cloud solution helps life science companies implement their cloud strategies in compliance with latest regulatory requirements.
Your Licence to Sell is at Stake
With an approaching serialisation deadline, following the introduction of new legislation in the pharmaceuticals market to deal with the threat of counterfeit drugs, Clinical Trials Insight talks to Lars Højberg, life sciences expert at NNIT, about the best strategy for complying with serialisation. Read the article here